8-K filing — BioXcel Therapeutics, Inc. (BTAI)
Filed: 2026-08-25 AccNo: 0001104659-26-100532 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
BioXcel Therapeutics Announces $1.25M Additional Loans From Oaktree With 20% Upfront Fee; Minimum Liquidity Covenant Cut To $250K From $3M, Must Reach Repayment Or Capital Deal By August 31
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 25, 2026, 11:19 AM
- Checked
- Aug 25, 2026, 11:19 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Why Ross Stores Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI, HOWL, SUGP, SDEV, ZKH, BTAI, SXTC, TREO, and ASST. Losers are JZ, DFNS, FLUX, and MMA.
Read original at benzingaWhy Flexsteel Industries Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Flexsteel Industries Inc (FLXS) reported better-than-expected Q4 results, with shares jumping 9% in pre-market trading. Other gainers include PFSA, EJH, XOS, WETO, SGLY, VOGX, WFF, AMLX, and ENRD. Losers include SNYR, XPON, NOMA, BTAI, and YOUL.
Read original at benzinga